Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 3104727, 8 pages
http://dx.doi.org/10.1155/2016/3104727
Review Article

Immunity and Tolerance Induced by Intestinal Mucosal Dendritic Cells

Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA

Received 6 November 2015; Revised 2 February 2016; Accepted 8 February 2016

Academic Editor: Hans Jacobs

Copyright © 2016 Julio Aliberti. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Hart, H. O. Al-Hassi, R. J. Rigby et al., “Characteristics of intestinal dendritic cells in inflammatory bowel diseases,” Gastroenterology, vol. 129, no. 1, pp. 50–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Kelsall, “Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages,” Mucosal Immunology, vol. 1, no. 6, pp. 460–469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. L. Coombes and F. Powrie, “Dendritic cells in intestinal immune regulation,” Nature Reviews Immunology, vol. 8, no. 6, pp. 435–446, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Johansson-Lindbom, M. Svensson, O. Pabst et al., “Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing,” Journal of Experimental Medicine, vol. 202, no. 8, pp. 1063–1073, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. Coombes, K. R. R. Siddiqui, C. V. Arancibia-Carcamo et al., “A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β− and retinoic acid-dependent mechanism,” The Journal of Experimental Medicine, vol. 204, no. 8, pp. 1757–1764, 2007. View at Publisher · View at Google Scholar
  6. E. Jaensson, H. Uronen-Hansson, O. Pabst et al., “Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans,” Journal of Experimental Medicine, vol. 205, no. 9, pp. 2139–2149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C.-M. Sun, J. A. Hall, R. B. Blank et al., “Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid,” Journal of Experimental Medicine, vol. 204, no. 8, pp. 1775–1785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Bersudsky, L. Luski, D. Fishman et al., “Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice,” Gut, vol. 63, no. 4, pp. 598–609, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Bogunovic, F. Ginhoux, J. Helft et al., “Origin of the lamina propria dendritic cell network,” Immunity, vol. 31, no. 3, pp. 513–525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. V. Ostanin, K. P. Pavlick, S. Bharwani et al., “T cell-induced inflammation of the small and large intestine in immunodeficient mice,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 290, no. 1, pp. G109–G119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Rescigno, M. Urbano, B. Valzasina et al., “Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria,” Nature Immunology, vol. 2, no. 4, pp. 361–367, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Schulz, E. Jaensson, E. K. Persson et al., “Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions,” Journal of Experimental Medicine, vol. 206, no. 13, pp. 3101–3114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Varol, A. Vallon-Eberhard, E. Elinav et al., “Intestinal lamina propria dendritic cell subsets have different origin and functions,” Immunity, vol. 31, no. 3, pp. 502–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. E. K. Persson, E. Jaensson, and W. W. Agace, “The diverse ontogeny and function of murine small intestinal dendritic cell/macrophage subsets,” Immunobiology, vol. 215, no. 9-10, pp. 692–697, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Varol, E. Zigmond, and S. Jung, “Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria,” Nature Reviews Immunology, vol. 10, no. 6, pp. 415–426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. H. Niess, S. Brand, X. Gu et al., “CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance,” Science, vol. 307, no. 5707, pp. 254–258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Chieppa, M. Rescigno, A. Y. C. Huang, and R. N. Germain, “Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement,” The Journal of Experimental Medicine, vol. 203, no. 13, pp. 2841–2852, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Vallon-Eberhard, L. Landsman, N. Yogev, B. Verrier, and S. Jung, “Transepithelial pathogen uptake into the small intestinal lamina propria,” Journal of Immunology, vol. 176, no. 4, pp. 2465–2469, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. L. Denning, Y.-C. Wang, S. R. Patel, I. R. Williams, and B. Pulendran, “Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses,” Nature Immunology, vol. 8, no. 10, pp. 1086–1094, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. L. Denning, B. A. Norris, O. Medina-Contreras et al., “Functional specializations of intestinal dendritic cell and macrophage subsets that control Th17 and regulatory T cell responses are dependent on the T cell/APC ratio, source of mouse strain, and regional localization,” Journal of Immunology, vol. 187, no. 2, pp. 733–747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Azukizawa, A. Döhler, N. Kanazawa et al., “Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells,” European Journal of Immunology, vol. 41, no. 5, pp. 1420–1434, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Guilliams, K. Crozat, S. Henri et al., “Skin-draining lymph nodes contain dermis-derived CD103 dendritic cells that constitutively produce retinoic acid and induce Foxp3+ regulatory T cells,” Blood, vol. 115, no. 10, pp. 1958–1968, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Bedoui, P. G. Whitney, J. Waithman et al., “Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells,” Nature Immunology, vol. 10, no. 5, pp. 488–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Henri, L. F. Poulin, S. Tamoutounour et al., “CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells,” The Journal of Experimental Medicine, vol. 207, no. 1, pp. 189–206, 2010. View at Publisher · View at Google Scholar
  25. L. Ohl, M. Mohaupt, N. Czeloth et al., “CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions,” Immunity, vol. 21, no. 2, pp. 279–288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. Hall, J. R. Grainger, S. P. Spencer, and Y. Belkaid, “The role of retinoic acid in tolerance and immunity,” Immunity, vol. 35, no. 1, pp. 13–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. C. H. Kim, “Roles of retinoic acid in induction of immunity and immune tolerance,” Endocrine, Metabolic & Immune Disorders-Drug Targets, vol. 8, no. 4, pp. 289–294, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. W. Fluhr, M.-P. Vienne, C. Lauze, P. Dupuy, W. Gehring, and M. Gloor, “Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions,” Dermatology, vol. 199, supplement 1, pp. 57–60, 1999. View at Google Scholar · View at Scopus
  29. R. Kurzrock, E. Estey, and M. Talpaz, “All-trans retinoic acid: tolerance and biologic effects in myelodysplastic syndrome,” Journal of Clinical Oncology, vol. 11, no. 8, pp. 1489–1495, 1993. View at Google Scholar · View at Scopus
  30. J. R. Mora, M. Iwata, B. Eksteen et al., “Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells,” Science, vol. 314, no. 5802, pp. 1157–1160, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Iwata, A. Hirakiyama, Y. Eshima, H. Kagechika, C. Kato, and S.-Y. Song, “Retinoic acid imprints gut-homing specificity on T cells,” Immunity, vol. 21, no. 4, pp. 527–538, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. S. G. Kang, H. W. Lim, O. M. Andrisani, H. E. Broxmeyer, and C. H. Kim, “Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells,” The Journal of Immunology, vol. 179, no. 6, pp. 3724–3733, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Svensson, B. Johansson-Lindbom, F. Zapata et al., “Retinoic acid receptor signaling levels and antigen dose regulate gut homing receptor expression on CD8+ T cells,” Mucosal Immunology, vol. 1, no. 1, pp. 38–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Takeuchi, A. Yokota, Y. Ohoka et al., “Efficient induction of CCR9 on T cells requires coactivation of retinoic acid receptors and retinoid X receptors (RXRs): exaggerated T cell homing to the intestine by RXR activation with organotins,” The Journal of Immunology, vol. 185, no. 9, pp. 5289–5299, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Harusato, K. L. Flannigan, D. Geem, and T. L. Denning, “Phenotypic and functional profiling of mouse intestinal antigen presenting cells,” Journal of Immunological Methods, vol. 421, pp. 20–26, 2015. View at Publisher · View at Google Scholar
  36. S. D. Lyman, L. James, J. Zappone, P. R. Sleath, M. P. Beckmann, and T. Bird, “Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene,” Oncogene, vol. 8, no. 4, pp. 815–822, 1993. View at Google Scholar · View at Scopus
  37. O. Rosnet, S. Marchetto, O. deLapeyriere, and D. Birnbaum, “Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family,” Oncogene, vol. 6, no. 9, pp. 1641–1650, 1991. View at Google Scholar · View at Scopus
  38. O. Rosnet, C. Schiff, M.-J. Pébusque et al., “Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells,” Blood, vol. 82, no. 4, pp. 1110–1119, 1993. View at Google Scholar · View at Scopus
  39. K. Brasel, S. Escobar, R. Anderberg, P. de Vries, H.-J. Gruss, and S. D. Lyman, “Expression of the flt3 receptor and its ligand on hematopoietic cells,” Leukemia, vol. 9, no. 7, pp. 1212–1218, 1995. View at Google Scholar · View at Scopus
  40. S. D. Lyman, L. James, L. Johnson et al., “Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells,” Blood, vol. 83, no. 10, pp. 2795–2801, 1994. View at Google Scholar · View at Scopus
  41. D. K. Fogg, C. Sibon, C. Miled et al., “A clonogenic bone marrow progenitor specific for macrophages and dendritic cells,” Science, vol. 311, no. 5757, pp. 83–87, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. A. D'Amico and L. Wu, “The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3,” The Journal of Experimental Medicine, vol. 198, no. 2, pp. 293–303, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Karsunky, M. Merad, A. Cozzio, I. L. Weissman, and M. G. Manz, “Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo,” The Journal of Experimental Medicine, vol. 198, no. 2, pp. 305–313, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. S. H. Naik, P. Sathe, H.-Y. Park et al., “Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo,” Nature Immunology, vol. 8, no. 11, pp. 1217–1226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Onai, A. Obata-Onai, M. A. Schmid, T. Ohteki, D. Jarrossay, and M. G. Manz, “Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow,” Nature Immunology, vol. 8, no. 11, pp. 1207–1216, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Aliberti, O. Schulz, D. J. Pennington et al., “Essential role for ICSBP in the in vivo development of murine CD8α+ dendritic cells,” Blood, vol. 101, no. 1, pp. 305–310, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Tsujimura, T. Tamura, C. Gongora et al., “ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro,” Blood, vol. 101, no. 3, pp. 961–969, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Schiavoni, F. Mattei, P. Sestili et al., “ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8α+ dendritic cells,” The Journal of Experimental Medicine, vol. 196, no. 11, pp. 1415–1425, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. K. L. Anderson, H. Perkin, C. D. Surh, S. Venturini, R. A. Maki, and B. E. Torbett, “Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells,” The Journal of Immunology, vol. 164, no. 4, pp. 1855–1861, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Guerriero, P. B. Langmuir, L. M. Spain, and E. W. Scott, “PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells,” Blood, vol. 95, no. 3, pp. 879–885, 2000. View at Google Scholar · View at Scopus
  51. N. Onai, A. Obata-Onai, R. Tussiwand, A. Lanzavecchia, and M. G. Manz, “Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development,” The Journal of Experimental Medicine, vol. 203, no. 1, pp. 227–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. K. M. Murphy, “Transcriptional control of dendritic cell development,” Advances in Immunology, vol. 120, pp. 239–267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Ginhoux, K. Liu, J. Helft et al., “The origin and development of nonlymphoid tissue CD103+ DCs,” The Journal of Experimental Medicine, vol. 206, no. 13, pp. 3115–3130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. N. S. Wilson, D. El-Sukkari, G. T. Belz et al., “Most lymphoid organ dendritic cell types are phenotypically and functionally immature,” Blood, vol. 102, no. 6, pp. 2187–2194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Uematsu, K. Fujimoto, M. H. Jang et al., “Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5,” Nature Immunology, vol. 9, no. 7, pp. 769–776, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Iwasaki and B. L. Kelsall, “Unique functions of CD11b+, CD8α+, and double-negative Peyer's patch dendritic cells,” Journal of Immunology, vol. 166, no. 8, pp. 4884–4890, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Kamada, S.-U. Seo, G. Y. Chen, and G. Núñez, “Role of the gut microbiota in immunity and inflammatory disease,” Nature Reviews Immunology, vol. 13, no. 5, pp. 321–335, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Kamada, G. Y. Chen, N. Inohara, and G. Núñez, “Control of pathogens and pathobionts by the gut microbiota,” Nature Immunology, vol. 14, no. 7, pp. 685–690, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Lotz, D. Gütle, S. Walther, S. Ménard, C. Bogdan, and M. W. Hornef, “Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells,” The Journal of Experimental Medicine, vol. 203, no. 4, pp. 973–984, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. L. E. Smythies, M. Sellers, R. H. Clements et al., “Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity,” The Journal of Clinical Investigation, vol. 115, no. 1, pp. 66–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. W. S. Garrett, G. M. Lord, S. Punit et al., “Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system,” Cell, vol. 131, no. 1, pp. 33–45, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Hudcovic, R. Štěpánková, J. Cebra, and H. Tlaskalová-Hogenová, “The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice,” Folia Microbiologica, vol. 46, no. 6, pp. 565–572, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Kirkland, A. Benson, J. Mirpuri et al., “B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage,” Immunity, vol. 36, no. 2, pp. 228–238, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Kitajima, M. Morimoto, E. Sagara, C. Shimizu, and Y. Ikeda, “Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice,” Experimental Animals, vol. 50, no. 5, pp. 387–395, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Vijay-Kumar, C. J. Sanders, R. T. Taylor et al., “Deletion of TLR5 results in spontaneous colitis in mice,” The Journal of Clinical Investigation, vol. 117, no. 12, pp. 3909–3921, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. S. M. Bloom, V. N. Bijanki, G. M. Nava et al., “Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease,” Cell Host and Microbe, vol. 9, no. 5, pp. 390–403, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. W. S. Garrett, C. A. Gallini, T. Yatsunenko et al., “Enterobacteriaceae Act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis,” Cell Host and Microbe, vol. 8, no. 3, pp. 292–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. O. Takeuchi and S. Akira, “Pattern recognition receptors and inflammation,” Cell, vol. 140, no. 6, pp. 805–820, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Schroder, R. Zhou, and J. Tschopp, “The NLRP3 inflammasome: a sensor for metabolic danger?” Science, vol. 327, no. 5963, pp. 296–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Franchi, N. Kamada, Y. Nakamura et al., “NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense,” Nature Immunology, vol. 13, no. 5, pp. 449–456, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Bauer, P. Duewell, H.-A. Lehr, S. Endres, and M. Schnurr, “Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors,” Digestive Diseases, vol. 30, no. 1, pp. 82–90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Bauer, P. Duewell, C. Mayer et al., “Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome,” Gut, vol. 59, no. 9, pp. 1192–1199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. I. C. Allen, E. M. Tekippe, R.-M. T. Woodford et al., “The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer,” Journal of Experimental Medicine, vol. 207, no. 5, pp. 1045–1056, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. M. H. Zaki, K. L. Boyd, P. Vogel, M. B. Kastan, M. Lamkanfi, and T.-D. Kanneganti, “The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis,” Immunity, vol. 32, no. 3, pp. 379–391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Coccia, O. J. Harrison, C. Schiering et al., “IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells,” Journal of Experimental Medicine, vol. 209, no. 9, pp. 1595–1609, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Saitoh, N. Fujita, M. H. Jang et al., “Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production,” Nature, vol. 456, no. 7219, pp. 264–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Schaale, K. M. Peters, A. M. Murthy et al., “Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli,” Mucosal Immunology, vol. 9, no. 1, pp. 124–136, 2015. View at Publisher · View at Google Scholar
  78. H. Yen, N. Sugimoto, and T. Tobe, “Enteropathogenic Escherichia coli uses NleA to inhibit NLRP3 inflammasome activation,” PLoS Pathogens, vol. 11, no. 9, Article ID e1005121, 2015. View at Publisher · View at Google Scholar
  79. N. Baba, S. Samson, R. L. Bourdet-Sicard, M. Rubio, and M. Sarfati, “Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells,” Journal of Leukocyte Biology, vol. 84, no. 2, pp. 468–476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. S. K. Mazmanian, H. L. Cui, A. O. Tzianabos, and D. L. Kasper, “An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system,” Cell, vol. 122, no. 1, pp. 107–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. I. I. Ivanov, K. Atarashi, N. Manel et al., “Induction of intestinal Th17 cells by segmented filamentous bacteria,” Cell, vol. 139, no. 3, pp. 485–498, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. K. Atarashi, J. Nishimura, T. Shima et al., “ATP drives lamina propria TH17 cell differentiation,” Nature, vol. 455, no. 7214, pp. 808–812, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Laffont, K. R. R. Siddiqui, and F. Powrie, “Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells,” European Journal of Immunology, vol. 40, no. 7, pp. 1877–1883, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. C. L. Scott, A. M. Aumeunier, and A. M. Mowat, “Intestinal CD103+ dendritic cells: master regulators of tolerance?” Trends in Immunology, vol. 32, no. 9, pp. 412–419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Semmrich, M. Plantinga, M. Svensson-Frej et al., “Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses,” Mucosal Immunology, vol. 5, no. 2, pp. 150–160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. F. Powrie, M. W. Leach, S. Mauze, S. Menon, L. B. Caddle, and R. L. Coffman, “Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells,” Immunity, vol. 1, no. 7, pp. 553–562, 1994. View at Publisher · View at Google Scholar · View at Scopus
  87. J.-B. Sun, S. Raghavan, Å. Sjöling, S. Lundin, and J. Holmgren, “Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells,” Journal of Immunology, vol. 177, no. 11, pp. 7634–7644, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Yokota, H. Takeuchi, N. Maeda et al., “GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity,” International Immunology, vol. 21, no. 4, pp. 361–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Bereswill, M. Muñoz, A. Fischer et al., “Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation,” PLoS ONE, vol. 5, no. 12, Article ID e15099, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. F. Fallarino, U. Grohmann, S. You et al., “The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells,” The Journal of Immunology, vol. 176, no. 11, pp. 6752–6761, 2006. View at Publisher · View at Google Scholar
  91. R. Elgueta, F. E. Sepulveda, F. Vilches et al., “Imprinting of CCR9 on CD4 T cells requires IL-4 signaling on mesenteric lymph node dendritic cells,” Journal of Immunology, vol. 180, no. 10, pp. 6501–6507, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Chmill, S. Kadow, M. Winter, H. Weighardt, and C. Esser, “2,3,7,8-tetrachlorodibenzo-p-dioxin impairs stable establishment of oral tolerance in mice,” Toxicological Sciences, vol. 118, no. 1, pp. 98–107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Takamura, D. Harama, S. Fukumoto et al., “Lactobacillus bulgaricus OLL1181 activates the aryl hydrocarbon receptor pathway and inhibits colitis,” Immunology and Cell Biology, vol. 89, no. 7, pp. 817–822, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. C. McBerry, R. M. S. Gonzalez, N. Shryock, A. Dias, and J. Aliberti, “SOCS2-induced proteasome-dependent TRAF6 degradation: a common anti-inflammatory pathway for control of innate immune responses,” PLoS ONE, vol. 7, no. 6, Article ID e38384, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. T. Varga and L. Nagy, “Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma,” European Journal of Clinical Investigation, vol. 38, no. 10, pp. 695–707, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. J. H. Cummings, E. W. Pomare, H. W. J. Branch, C. P. E. Naylor, and G. T. MacFarlane, “Short chain fatty acids in human large intestine, portal, hepatic and venous blood,” Gut, vol. 28, no. 10, pp. 1221–1227, 1987. View at Publisher · View at Google Scholar · View at Scopus
  97. C. Nastasi, M. Candela, C. M. Bonefeld et al., “The effect of short-chain fatty acids on human monocyte-derived dendritic cells,” Scientific Reports, vol. 5, article 16148, 2015. View at Publisher · View at Google Scholar
  98. N. Singh, A. Gurav, S. Sivaprakasam et al., “Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis,” Immunity, vol. 40, no. 1, pp. 128–139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. Y. Cong, L. Wang, A. Konrad, T. Schoeb, and C. O. Elson, “Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells,” European Journal of Immunology, vol. 39, no. 11, pp. 3134–3146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. C. T. Taylor and S. J. Keely, “The autonomic nervous system and inflammatory bowel disease,” Autonomic Neuroscience: Basic and Clinical, vol. 133, no. 1, pp. 104–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. Y. Weng, J. Sun, Q. Wu, and J. Pan, “Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells,” Journal of Neuroimmunology, vol. 182, no. 1-2, pp. 48–54, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. M. G. Toscano, M. Delgado, W. Kong, F. Martin, M. Skarica, and D. Ganea, “Dendritic cells transduced with lentiviral vectors expressing vip differentiate into vip-secreting tolerogenic-like DCs,” Molecular Therapy, vol. 18, no. 5, pp. 1035–1045, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Delgado, E. Gonzalez-Rey, and D. Ganea, “The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells,” The Journal of Immunology, vol. 175, no. 11, pp. 7311–7324, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Delgado, A. Chorny, E. Gonzalez-Rey, and D. Ganea, “Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo,” Journal of Leukocyte Biology, vol. 78, no. 6, pp. 1327–1338, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. E. Gonzalez-Rey and M. Delgado, “Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide,” Gastroenterology, vol. 131, no. 6, pp. 1799–1811, 2006. View at Publisher · View at Google Scholar · View at Scopus